What is the appropriate next step in management for a patient with a suppressed TSH (<0.0005 µIU/mL) and elevated free T4 (5.88 ng/dL)?

Immediate Management: Confirm Overt Hyperthyroidism and Initiate Treatment

This patient has overt hyperthyroidism with a profoundly suppressed TSH (<0.0005 µIU/mL) and significantly elevated free T4 (5.88 ng/dL, assuming normal range ~0.8-2.0 ng/dL), requiring immediate confirmation with total T3 measurement and prompt initiation of antithyroid drug therapy with methimazole while determining the underlying etiology.

Algorithmic Approach to Management

Step 1: Complete the Biochemical Assessment

• Measure total T3 immediately 1 - TSH alone with free T4 is insufficient when TSH is profoundly suppressed (<0.05 mU/L), as you need to assess the full degree of thyrotoxicosis 2
• The combination of suppressed TSH and elevated free T4 confirms thyrotoxicosis, but T3 levels guide treatment intensity and help differentiate T3-predominant conditions

Step 2: Determine the Etiology

Before initiating treatment, obtain:

• TSH receptor antibodies (TRAb) - if positive, confirms Graves' disease
• Thyroid uptake and scan - if TRAb negative or unavailable, this differentiates:
  • High uptake: Graves' disease or toxic nodular disease
  • Low uptake: Thyroiditis, exogenous thyroid hormone, or other causes
• Thyroid ultrasound - assesses for nodules, goiter, or thyroiditis features

Step 3: Initiate Antithyroid Drug Therapy

Methimazole is the preferred initial therapy 1:

• Start methimazole 10-30 mg daily (dose depends on severity; with free T4 this elevated, consider 20-30 mg daily)
• Exceptions where propylthiouracil (PTU) should be used instead:
  • First trimester pregnancy
  • Thyroid storm
  • Minor reactions to methimazole in patients refusing radioactive iodine or surgery

Step 4: Baseline Safety Monitoring

Before starting antithyroid drugs 1:

• Complete blood count with differential (baseline white count)
• Liver function tests (transaminases and bilirubin)
• Counsel the patient to immediately stop medication and contact you if they develop:
  • Fever, sore throat (agranulocytosis warning)
  • Jaundice, dark urine, pale stools, severe fatigue (hepatotoxicity warning)
  • Pruritic rash, arthralgias, abdominal pain

Critical Pitfalls to Avoid

Don't Rely on TSH Alone for Monitoring

TSH remains suppressed for 1 month or longer after hyperthyroidism resolves 1. During treatment:

• Monitor free T4 and total T3 at 4-6 week intervals initially
• TSH will lag behind and should be interpreted cautiously only in concert with free thyroid hormones

Rule Out Assay Interference

While less likely with this degree of elevation, consider 3:

• Biotin interference - ask about high-dose biotin supplements (>5 mg daily); stop 2-3 days before retesting if present
• Heterophile antibodies or other immunoassay interference - if clinical picture doesn't match biochemistry
• TSH-secreting pituitary adenoma or thyroid hormone resistance - extremely rare but characterized by elevated free T4 with non-suppressed TSH (your patient's TSH IS suppressed, making these unlikely)

Don't Delay Treatment

With free T4 at 5.88 ng/dL (approximately 3-fold elevation if normal range is ~0.8-2.0), this patient is at risk for:

• Cardiovascular complications (atrial fibrillation, heart failure)
• Thyroid storm if stressed (infection, surgery, trauma)
• Bone loss and metabolic complications

Beta-blocker therapy (propranolol 20-40 mg three times daily or atenolol 25-50 mg daily) should be considered for symptomatic relief while awaiting antithyroid drug effect, particularly if tachycardia, tremor, or anxiety is present.

Follow-Up Timeline

• 4-6 weeks: Recheck free T4 and total T3 (not TSH) 1
• Continue monitoring every 4-6 weeks until euthyroid
• Once stable, determine definitive management (continued antithyroid drugs, radioactive iodine, or surgery) based on etiology and patient preference
• TSH normalization typically takes 2-3 months after thyroid hormones normalize